The rise of the biosimilar

ISSN： 1751-2433

Source： Expert Review of Clinical Pharmacology, Vol.5, Iss.6, 2012-11, pp. : 597-599

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statistical Assessment of Biosimilar Products

By Chow Shein-Chung

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 10-30

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Consistency Approach for Evaluation of Biosimilar Products

By Tsou Hsiao-Hui Chang Wan-Jung Hwang Wong-Shian Lai Yi-Hsuan

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1054-1066

Taylor & Francis Ltd

Access to resources Recommend Favorite

Biosimilar Medicines—New Challenges for a New Class of Medicine

By Fox Andrew

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 3-9

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Calculations for the Development of Biosimilar Products

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 6, 2014-11 ,pp. : 1215-1224

Taylor & Francis Ltd

Access to resources Recommend Favorite

Scientific Factors and Current Issues in Biosimilar Studies

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 6, 2014-11 ,pp. : 1138-1153

Taylor & Francis Ltd

Access to resources Recommend Favorite